The risk of clopidogrel resistance is associated with ABCB1 polymorphisms but not promoter methylation in a Chinese Han population.
The goal of our study was to investigate the contribution of ABCB1 expression to the risk of clopidogrel resistance (CR). Platelets functions were measured using the Verify-Now P2Y12 assay. Applying Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP), the single-nucleotide...
Main Authors: | Jia Su, Qinglin Yu, Hao Zhu, Xiaojing Li, Hanbin Cui, Weiping Du, Lindan Ji, Maoqing Tong, Yibo Zheng, Hongyu Xu, Jianjiang Zhang, Yunyun Zhu, Yezi Xia, Ting Liu, Qi Yao, Jun Yang, Xiaomin Chen, Jingbo Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5373545?pdf=render |
Similar Items
-
ABCB1 polymorphism in clopidogrel-treated Montenegrin patients
by: Mugosa Snezana, et al.
Published: (2021-02-01) -
Clopidogrel Resistance Is Associated With DNA Methylation of Genes From Whole Blood of Humans
by: Jin Yang, et al.
Published: (2021-01-01) -
Association of P2Y12 Gene Promoter DNA Methylation with the Risk of Clopidogrel Resistance in Coronary Artery Disease Patients
by: Jia Su, et al.
Published: (2014-01-01) -
ABCB1 C3435T polymorphism and response to clopidogrel treatment in coronary artery disease (CAD) patients: a meta-analysis.
by: Jia Su, et al.
Published: (2012-01-01) -
Associations of PER3 polymorphisms with clopidogrel resistance among Chinese Han people treated with clopidogrel
by: Chen, X., et al.
Published: (2021)